Size, structure help poziotinib pose threat to deadly exon 20 lung cancer
A drug that failed to effectively strike larger targets in lung cancer hits a bulls-eye on the smaller target presented by a previously untreatable form of the disease, researchers at The University of Texas MD Anderson Cancer ...
Apr 23, 2018
0
44